Delivery Order SPE2DB20D2104-SPE2DB24FU76W
Award Date
6/18/24
Potential Completion Date
6/20/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the U.S. Department of Defense. The contract, valued at $2,502.84, is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of June 20, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565214153 TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract is a Delivery Order with a Firm Fixed Price of $1,062.78 and an ultimate completion date of July 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg. The firm-fixed-price contract, valued at $1,897.20, has a period of performance through December 19, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract has a ceiling value of $3,951.88 and a performance period through February 10, 2025. This award is under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $15,804.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a medication, to support military treatment programs and facilities. The contract has a firm fixed-price pricing type and an ultimate completion date of September 10, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,478.23 firm fixed-price delivery order is for TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a period of performance through January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,605.41 firm fixed-price delivery order is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, with a completion date of February 5, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 capsules of Tamsulosin Hydrochloride 0.4 mg. The Firm Fixed Price contract, valued at $1,874.12, has a completion date of June 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
This federal contract award is for the delivery of 1,000 units of the prescription medication TAMSULOSIN HCL 0.4 MG CAPSULE. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a firm fixed price of $2,934.31 and a performance period through April 5, 2024. This award is a delivery order under a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Defense Logistics Agency (DLA). The contract, valued at $2,265.22, is a delivery order with a firm fixed price. The award date is October 8, 2024, and the ultimate completion date is October 9, 2024. This contract is not a set-aside. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts by...